Journal of Leukocyte Biology eBioscience full spectrum cell analysis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vermeire, K.
Right arrow Articles by Billiau, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vermeire, K.
Right arrow Articles by Billiau, A.
(Journal of Leukocyte Biology. 2000;68:119-124.)
© 2000 by Society for Leukocyte Biology

The effects of NO synthase inhibitors on murine collagen-induced arthritis do not support a role of NO in the protective effect of IFN-{gamma}

Kurt Vermeire, Leen Thielemans, Patrick Matthys and Alfons Billiau

Laboratory of Immunobiology, Rega Institute, University of Leuven, Faculty of Medicine, B-3000 Leuven, Belgium

Correspondence: Dr. A. Billiau, Rega Institute, University of Leuven, Laboratory of Immunobiology, Minderbroedersstraat 10, B-3000 Leuven, Belgium. E-mail: Alfons.Billiau{at}rega.kuleuven.ac.be

DBA/1 mice deficient in expressing the interferon-{gamma} (IFN-{gamma}) membrane receptor (IFN-{gamma}R KO mice) are more susceptible to collagen-induced arthritis (CIA) than wild-type mice, indicating that endogenous IFN-{gamma} plays a protective role in the pathogenesis of CIA. In IFN-{gamma}R KO mice, nitric oxide (NO) production during CIA is impaired. Because NO is known to exert immunosuppressive and anti-inflammatory effects in certain model systems, the protective effect of IFN-{gamma} might be mediated by NO. Here, we tested in wild-type mice whether inhibition of NO production by metabolic inhibitors, aminoguanidine (AG) and L-N-(1-iminoethyl)lysine (L-NIL), could mimic the ablation of the IFN-{gamma} receptor. A high-dose regimen of AG supplied in the drinking water inhibited NO production, disease development, and anticollagen antibody production but was also associated with transient body weight loss. At a dose and time regimen that still inhibited NO production but did not cause body weight loss, AG failed to affect disease scores. Treatment with L-NIL, which more specifically than AG affects inducible NO production, caused a slight increase in anticollagen antibody production although not significantly affecting disease occurrence. These data indicate that the diminished capacity of the IFN-{gamma}R KO mice to produce NO following immunization with collagen is unlikely to account for their higher susceptibility to CIA.

Key Words: interferon-{gamma} • nitric oxide • collagen-induced arthritis




This article has been cited by other articles:


Home page
Infect. Immun.Home page
O. Hoffmann, C. Mahrhofer, N. Rueter, D. Freyer, B. Bert, H. Fink, and J. R. Weber
Pneumococcal Cell Wall-Induced Meningitis Impairs Adult Hippocampal Neurogenesis
Infect. Immun., September 1, 2007; 75(9): 4289 - 4297.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
B.-G. Xiao, X.-C. Wu, J.-S. Yang, L.-Y. Xu, X. Liu, Y.-M. Huang, B. Bjelke, and H. Link
Therapeutic potential of IFN-{gamma}-modified dendritic cells in acute and chronic experimental allergic encephalomyelitis
Int. Immunol., January 1, 2004; 16(1): 13 - 22.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Ohtsuka, F. Konno, H. Honda, T. Oikawa, M. Ishikawa, N. Iwase, K. Isomae, F. Ishii, H. Hemmi, and S. Sato
PPA250 [3-(2,4-Difluorophenyl)-6-{2-[4-(1H-imidazol-1-ylmethyl) Phenoxy]ethoxy}-2-phenylpyridine], a Novel Orally Effective Inhibitor of the Dimerization of Inducible Nitric-Oxide Synthase, Exhibits an Anti-Inflammatory Effect in Animal Models of Chronic Arthritis
J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 52 - 57.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Matthys, S. Hatse, K. Vermeire, A. Wuyts, G. Bridger, G. W. Henson, E. De Clercq, A. Billiau, and D. Schols
AMD3100, a Potent and Specific Antagonist of the Stromal Cell-Derived Factor-1 Chemokine Receptor CXCR4, Inhibits Autoimmune Joint Inflammation in IFN-{gamma} Receptor-Deficient Mice
J. Immunol., October 15, 2001; 167(8): 4686 - 4692.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the Society for Leukocyte Biology.